Download
40729_2024_Article_577.pdf 1,50MB
WeightNameValue
1000 Titel
  • Antibiotic prophylaxis in oral implant surgery in Germany: a cross-sectional study
1000 Autor/in
  1. Peter, Jens-Uwe |
  2. Ladewig, Johannes |
  3. Stoll, Christian |
  4. Zolk, Oliver |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-12-16
1000 Erschienen in
1000 Quellenangabe
  • 10(1):62
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40729-024-00577-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649591/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>Prophylactic antibiotics are used in dental implants to reduce infection risk and implant failure, especially benefiting patients with risk factors. However, evidence suggests that using clindamycin or extending antibiotics postoperatively has an unfavorable risk–benefit ratio.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>This national cross-sectional study analyzed antibiotic prophylaxis during implant insertion across Germany. Dentists from the German Society for Oral Implantology (DGOI) provided demographic information and data on the next 10 consecutive implant patients, including age, sex, risk factors, type of implantation, and antibiotic details.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>103 dentists participated, providing data on 1040 patients. Most dentists were male and aged 30–64. Patients were evenly split between genders, with an average age of 51 years. Antibiotics were administered in 87.6% of all cases, more frequently for patients undergoing bone augmentation (OR 7.01, p &lt; 0.0001), immediate (OR 3.11, p = 0.002) or delayed (OR 5.30, p &lt; 0.0001) implant insertion, and those with cardiovascular disease (OR 3.24, p = 0.009). 74.8% of implantologists tended to use antibiotic prophylaxis routinely, while the remaining implantologists decided on a case-by-case basis. Implantologists primarily used aminopenicillins for 63.8% of prescriptions and clindamycin for the remaining 35.6%. Additionally, 78.8% of patients with prophylaxis received postoperative, multi-day treatments.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>The study reveals extensive antibiotic use for perioperative prophylaxis in implant surgery, often not justified by current recommendations, particularly concerning the choice of antibiotic (e.g., clindamycin) and duration (e.g., postoperative use). Specialized clinical guidelines and targeted training for dentists on antibiotic prophylaxis are needed.</jats:p> </jats:sec><jats:sec> <jats:title>Graphical Abstract</jats:title> </jats:sec>
1000 Sacherschließung
lokal Aged [MeSH]
lokal Germany
lokal Anti-bacterial agents
lokal Dental Implantation, Endosseous [MeSH]
lokal Risk Factors [MeSH]
lokal Antibiotic prophylaxis
lokal Germany/epidemiology [MeSH]
lokal Surgical Wound Infection/epidemiology [MeSH]
lokal Anti-Bacterial Agents/administration
lokal Male [MeSH]
lokal Dental Implantation/methods [MeSH]
lokal Surgical Wound Infection/prevention
lokal Female [MeSH]
lokal Anti-Bacterial Agents/therapeutic use [MeSH]
lokal Adult [MeSH]
lokal Dental Implants [MeSH]
lokal Humans [MeSH]
lokal Middle Aged [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Surveys and questionnaires
lokal Dental health services
lokal Drug prescriptions
lokal Research
lokal Antibiotic Prophylaxis/methods [MeSH]
lokal Dental implants
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UGV0ZXIsIEplbnMtVXdl|https://frl.publisso.de/adhoc/uri/TGFkZXdpZywgSm9oYW5uZXM=|https://frl.publisso.de/adhoc/uri/U3RvbGwsIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/Wm9saywgT2xpdmVy
1000 Hinweis
  • DeepGreen-ID: a532151997354bb48b59043a5d2ed401 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Medizinische Hochschule Brandenburg CAMPUS GmbH |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Medizinische Hochschule Brandenburg CAMPUS GmbH |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6520467.rdf
1000 Erstellt am 2025-07-06T01:09:32.033+0200
1000 Erstellt von 322
1000 beschreibt frl:6520467
1000 Zuletzt bearbeitet 2025-08-05T11:49:37.165+0200
1000 Objekt bearb. Tue Aug 05 11:49:37 CEST 2025
1000 Vgl. frl:6520467
1000 Oai Id
  1. oai:frl.publisso.de:frl:6520467 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source